arrow
H

Hugo F. Fernández

cy cergy paris université
H指数:44
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Post-transplant MRD Monitoring by TP53 Duplex Sequencing with APR-246 + Azacitidine Maintenance Predicts Outcomes

移植后微小残留病(MRD)通过TP53双测序结合APR-246 + 去氧氟尿苷维持治疗预测预后

2025-11-270
OAAI
Melphalan Dose in Combination With Fludarabine Affects Gastrointestinal Toxicity and Graft-Versus-Host Disease After Allogeneic Transplantation in Acute Myeloid Leukemia and Myelodysplastic Syndromes

美法仑剂量联合氟达拉滨影响急性髓系白血病和骨髓增生异常综合征异基因移植后胃肠道毒性和移植物抗宿主病

2024-11-010
PRE
Lower Weight-Based Mycophenolate Mofetil Dosing is Associated with Superior Outcomes after Haploidentical Hematopoietic Cell Transplant with Post-transplant Cyclophosphamide
2024-10-011
PRE
Sirolimus Is an Acceptable Alternative to Tacrolimus for Graft-versus-Host Disease Prophylaxis after Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide
2024-02-015
PRE
Integrative analysis identifies an older female-linked AML patient group with better risk in ECOG-ACRIN Cancer Research Group's clinical trial E3999 (vol 12, 137,2022)
2023-07-060
OAAI
Obesity in adult acute myeloid leukemia is not associated with inferior response or survival even when dose capping anthracyclines: An ECOG-ACRIN analysis

成人急性髓性白血病的肥胖与不良反应或生存率无关,即使剂量上限为蒽环类药物: ECOG-ACRIN分析

CANCER
IF5.1
2023-04-252
PRE
Integrative analysis identifies an older female-linked AML patient group with better risk in ECOG-ACRIN Cancer Research Group's clinical trial E3999
2022-09-232
OAAI
A phase 2 multicenter trial of ofatumumab and prednisone as initial therapy for chronic graft-versus-host disease
2022-01-106
OAAI
TET2 and DNMT3A Mutations Exert Divergent Effects on DNA Repair and Sensitivity of Leukemia Cells to PARP Inhibitors

TET2和DNMT3A突变对DNA修复和白血病细胞对PARP抑制剂的敏感性产生不同的影响

2021-07-0227
OA
Myeloablative versus Reduced-Intensity Conditioning for Hematopoietic Cell Transplantation in Acute Myelogenous Leukemia and Myelodysplastic Syndromes-Long-Term Follow-Up of the BMT CTN 0901 Clinical Trial

急性髓性白血病和骨髓增生异常综合征中造血细胞移植的清髓性与低强度预处理-BMT CTN 0901临床试验的长期随访

2021-06-0188
OAAI
ELN 2017 Genetic Risk Stratification Predicts Survival of Acute Myeloid Leukemia Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation

ELN 2017遗传风险分层预测接受异基因造血干细胞移植的急性髓系白血病患者的生存

2021-03-0113
OAAI
A phase 2 trial of GVHD prophylaxis with PTCy, sirolimus, and MMF after peripheral blood haploidentical transplantation
2021-02-2628
OA
TGFβR-SMAD3 Signaling Induces Resistance to PARP Inhibitors in the Bone Marrow Microenvironment

TGFβR-SMAD3信号在骨髓微环境中诱导对PARP抑制剂的抗性

2020-10-0120
OAAI
Plerixafor alone for the mobilization and transplantation of HLA-matched sibling donor hematopoietic stem cells
2019-03-1929
OA